ADAR and ovarian carcinoma: This study revealed a new ADAR1/R-loop/ATR pathway that is crucial for ovarian cancer progression, and the exploration of ADAR1 inhibitors and ATR inhibitors may be a good direction for future treatment of ovarian cancer.